Q2 2020 13F Holders as of 6/30/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
237M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
48.8M
-
Shares change
-
+358K
-
Total reported value, excl. options
-
$143M
-
Value change
-
+$1.12M
-
Put/Call ratio
-
2.08
-
Number of buys
-
51
-
Number of sells
-
-41
-
Price
-
$2.93
Significant Holders of ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) as of Q2 2020
116 filings reported holding ADMA - ADMA BIOLOGICS, INC. - COMMON STOCK as of Q2 2020.
ADMA BIOLOGICS, INC. - COMMON STOCK (ADMA) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.8M shares
of 237M outstanding shares and own 20.6% of the company stock.
Largest 10 shareholders include PERCEPTIVE ADVISORS LLC (16.6M shares), BlackRock Inc. (5.72M shares), VANGUARD GROUP INC (3.51M shares), Consonance Capital Management LP (2.66M shares), 683 Capital Management, LLC (2M shares), SPHERA FUNDS MANAGEMENT LTD. (1.98M shares), Prosight Management, LP (1.3M shares), STATE STREET CORP (1.24M shares), GEODE CAPITAL MANAGEMENT, LLC (1.09M shares), and FRANKLIN RESOURCES INC (1.03M shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.